Chest CT revealed persistent lung abnormalities in patients two years after COVID-19, according to a study published in Radiology. This is the first research paper with two-year follow-up data on COVID-19 lung effects.
Feb 14, 2023
0
16
New research published in Cell Death & Disease covers the first batch of results from collaborative work directed to perform multi-omics-based analyses in the context of age-related diseases using an AI-driven target and ...
Dec 1, 2022
0
4
Researchers at National Jewish Health have shown that vapor from electronic cigarettes increases small airway inflammation response to influenza A infections. The findings show that short-term exposure of just three days ...
Nov 14, 2022
0
11
Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF). Saracatinib worked as well or better than two approved drugs at reducing tissue scarring in preclinical ...
Oct 13, 2022
1
37
Idiopathic pulmonary fibrosis could become the first degenerative disease to be treated through the science of aging.
Oct 6, 2022
0
54
In the last decade, timely and efficient diagnoses of idiopathic pulmonary fibrosis (IPF), a lethal disease that causes scarring of the lung tissue and affects the ability to breathe and be active, has become recognized as ...
Sep 29, 2022
0
17
An experimental cancer drug with a favorable safety profile shows promise as a treatment for Idiopathic Pulmonary Fibrosis (IPF), according to a study published on August 23, 2022, in the American Journal of Respiratory and ...
Sep 1, 2022
0
302
A Nagoya University research group has developed an AI algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis, a lung disease. The algorithm makes its diagnosis based only on information from non-invasive ...
Jul 28, 2022
0
5
A new diagnostic method could help identify one of the deadliest types of interstitial lung disease (ILD) sooner, allowing for faster treatment and improved patient outcomes.
Jul 26, 2022
0
6
Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease caused by progressive scarring of the lungs, leading to respiratory failure and death. Therapies to treat IPF are limited, making studies on the mechanisms ...
Jul 25, 2022
0
91
